{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320221420160.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1097/00008571-200112000-00002"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/00008571-200112000-00002"}}],"dc:title":[{"@value":"Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320221420162","@type":"Researcher","foaf:name":[{"@value":"Robert R. Freimuth"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320221420160","@type":"Researcher","foaf:name":[{"@value":"Bruce Eckloff"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320221420161","@type":"Researcher","foaf:name":[{"@value":"Eric D. Wieben"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320221420288","@type":"Researcher","foaf:name":[{"@value":"Richard M. Weinshilboum"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0960314X"}],"prism:publicationName":[{"@value":"Pharmacogenetics"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2001-12","prism:volume":"11","prism:number":"9","prism:startingPage":"747","prism:endingPage":"756"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/00008571-200112000-00002"}],"createdAt":"2003-04-24","modifiedAt":"2021-06-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360576118798990464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"SULT genetic polymorphisms: physiological, pharmacological and clinical implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1362541648443842688","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/00008571-200112000-00002"},{"@type":"CROSSREF","@value":"10.1080/17425255.2021.1940952_references_DOI_JboFCyxoW1etvdR1sSfSsWxAV2M"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2014.10.004_references_DOI_JboFCyxoW1etvdR1sSfSsWxAV2M"}]}